ArticleAmerican journal of translational research2025
Expression of Serum Ferritin, Human neutrophil lipocalin, Procalcitonin, and inflammatory factors in children with Kawasaki disease and their relationship to coronary artery lesions.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The expression of C-reactive protein, erythrocyte sedimentation rate, and procalcitonin in children with Kawasaki disease and their correlation with coronary artery ectasia.BMC pediatrics · 2026Article
- Immunophenotype of Kawasaki Disease: Insights into Pathogenesis and Treatment Response.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the levels of serum ferritin (SF), human neutrophil lipocalin (HNL), procalcitonin (PCT), and inflammatory cytokines (IL-6, IL-10, IL-17, IL-18, TNF-α, INF-γ, and sCD25) in Kawasaki disease (KD) and their relationship with coronary artery lesions (CAL).
methodsA retrospective analysis was conducted on 76 children with KD treated from May 2022 to May 2024. Participants were classified into a lesion group (n=48) and a no-lesion group (n=28) based on CAL status. Additionally, 76 healthy children were included as controls. Patients with CAL were further categorized into three subgroups based on coronary artery dilation: mild dilation (n=21), moderate dilation (n=18) and coronary artery aneurysm (n=9). The correlation between indicator levels and CAL severity, as well as coronary artery diameter at admission, was analyzed. Partial regression was used to identify inflammatory factors associated with CAL.
resultsThe lesion group showed significantly higher levels of serum SF, HNL, PCT, and all seven inflammatory cytokines at admission compared to the no-lesion and control groups (all P<0.05). Among patients with CAL, those with coronary artery aneurysms exhibited the highest levels of these indicators compared to the moderate dilation subgroup (P<0.05). Serum levels of SF, HNL, PCT, and inflammatory cytokines were positively correlated with CAL severity and coronary artery diameter. Logistic regression analysis identified these markers as risk factors for CAL in KD. The area under the curve (AUC) for IL-18 was 0.891, with a sensitivity of 0.643 and a specificity of 0.042.
conclusionsSerum SF, HNL, PCT, IL-17, IL-18, and TNF-α are implicated in CAL development in children with KD and may assist in the early clinical diagnosis of CAL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.